Duda-Król W, Jórasz I, Dabrowska M, Polubiec A, Kusz-Rynkun A
Katedry i Kliniki Chorób Wewnetrznych i Hematologii Akademii Medycznej w Warszawie.
Wiad Lek. 2000;53(7-8):454-7.
Lipid disorders have been treated with fibrates for many years. Rhabdomyolysis is one of the side effects of these drugs. We report a case of a septic-toxic shock due to rhabdomyolysis in a 75-year old patient, who had been treated with fenofibrate for 2 years. This case shows necessity of the standard monitoring of aminotransferase, phosphocreatine kinase and creatinine levels during treatment with fibrates.
